NCT05117242 2025-11-06Safety and Efficacy Study of GEN1046 as a Single Agent or in Combination With Pembrolizumab for Treatment of Recurrent (Non-small Cell) Lung CancerGenmabPhase 2 Active not recruiting125 enrolled
NCT05668650 2024-07-16Double-blind Study to Evaluate the PK, Efficacy, Safety and Immunogenicity of MB12 Versus Keytruda® in Stage IV NSCLCLaboratorio Elea Phoenix S.A.Phase 3 Recruiting174 enrolled